ENTITY
Celltrion Inc

Celltrion Inc (068270 KS)

462
Analysis
Health CareSouth Korea
Celltrion Inc. produces and sells biosimilar products and also provides consignm ent processing service for other companies. The Company's main product is Abata cept which is for arthritis treatment
more
Refresh
bullishCelltrion Inc
15 Nov 2023 01:12

Progress of Merger Between Celltrion Inc and Celltrion Healthcare & Appraisal Rights Issue

On 14 November, Celltrion Inc announced the total amount of stock purchase rights exercised in the merger of Celltrion Inc and Celltrion Healthcare...

Logo
906 Views
Share
bullishCelltrion Inc
02 Nov 2023 05:40

Celltrion Merger: Appraisal Rights & Passive Flows

The appraisal rights exercise period ends 13 Nov. Both companies are buying back shares. The last traded price is close to the appraisal price....

Logo
471 Views
Share
bullishCelltrion Inc
24 Oct 2023 10:13

Celltrion Merger: Index Implications

Celltrion Inc (068270 KS) and Celltrion Healthcare (091990 KS) shareholders have approved the merger. The last trading day is expected to be 28...

Logo
1.1k Views
Share
bearishCelltrion Inc
24 Oct 2023 07:15

Celltrion Merger Swap Event: Trading Dynamics Post-Merger Approval

This post explores the trading dynamics after the Celltrion merger approval, where a notable spread widening is anticipated due to the higher cost...

Logo
520 Views
Share
bullishCelltrion Inc
01 Sep 2023 08:51

(Mostly) Asia M&A, Aug 2023: Celltrion Inc/Healthcare, Itochu Techno, UMW, Boustead, SK Rent

For the month of August, 11 new deals were discussed on Smartkarma with an overall deal size of ~US$29bn. The average premium for the new deals...

Logo
523 Views
Share
x